Patrick Ruane, 55, was found guilty at the Old Bailey of two charges of encouraging terrorism in a series of Telegram posts ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

More than one in two Irish parents say their child missed schools days in the past year due to flu or flu-like symptoms with ...

TG4050 is the only individualized neoantigen cancer vaccine currently being developed in a randomized ... The reduction in total operating revenue reflects the discontinuation of the AstraZeneca ...

Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

This strategic move positions BioVaxys alongside major players like AstraZeneca and Genentech, enhancing its role in developing priority vaccine programs. For further insights into TSE:BIOV stock, ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

The 868-page report of the official inquiry into Australia’s Covid-19 response, like the inquiry itself, is not fit for ...

Tickets are available – and registration will be open right up until the day of the event – for the 2024 Protein Science in ...

In 2021, the family pledged £50million to Oxford university for a new Poonawalla Vaccines Research Building, having manufactured hundreds of millions of doses of the Oxford/AstraZeneca vaccine.

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

This column, forecasting a Trump election win, last week expressed surprise so many news consumers remain loyal to media ...